Advertisement

Do Biochemical Predictors of IVF Outcome Exist?

  • Anthony E. Michael
Chapter

Abstract

Over the past two decades, several molecules (predominantly steroids and proteins) have been explored as potential predictors of IVF outcome. This chapter begins by reviewing the equivocal data for and against “the usual suspects” (ovarian steroids, gonadotrophins, prolactin, etc.) before focusing on the cortisol — Cortisol binding globulin (CBG) - 11 β-hydroxysteroid dehydrogenase (11 βHSD) system. This example has been selected to illustrate how independent studies can reach different clinical conclusions, possibly due to differences in the methods used to obtain and assay samples. In the latter sections of this chapter, ongoing molecular studies, which appear to resolve the controversies surrounding assessments of cortisol metabolism as biochemical predictors of IVF outcome, are summarised. The chapter closes by providing an answer to the essential question: “Do biochemical predictors of IVF outcome exist?”

Keywords

Granulosa Cell Follicular Fluid Hydroxysteroid Dehydrogenase Human Granulosa Cell Cortisol Metabolism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abuzeid, M. and Sasy, M. (1996). Elevated progesterone levels in the late follicular phase do not predict success of in vitro fertilization-embryo transfer. Fertil. Steril 65: 981–985.PubMedGoogle Scholar
  2. Agarwal, A., Monder, C., Eckstein, B., and White, P. (1989). Cloning and expression of rat cDNA encoding corticosteroid 11 ß-dehydrogenase. J. Bio. Chem. 264:18939–18943.Google Scholar
  3. Agrawal, R., Tan, S., Wild, S., et al. (1999). Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome. Fertil. Steril. 71: 287–293.PubMedGoogle Scholar
  4. Albiston A., Obeyesekere, V., Smith, R. and Krozowski, Z. (1994). Cloning and tissue distribution of the human 11 ß-hydroxysteroid dehydrogenase type 2 enzyme. Mol.Cel Endocr. 105: R11–R17.Google Scholar
  5. Andersen, C. (1990). Levels of steroid binding proteins and steroids in human preovulatory follicle fluid and serum as predictors of success in in vitro fertilization-embryo transfer treatment. J. Clin. Endocr. and Metabol. 39: 835–838.Google Scholar
  6. Andersen, C. (1993). Characteristics of human follicular fluid associated with successful conception after in vitro fertilization. J. Clin. Endocr. Metabol. 77: 1227–1234.Google Scholar
  7. Andersen, C. and Hornnes, P. (1994). Intrafollicular concentrations of free cortisol close to follicular rupture. Hum. Reprod. 9: 1944–1949.PubMedGoogle Scholar
  8. Andersen, C. and Ziebe, S. (1992). Serum levels of free androstenedione, testosterone and oestradiol are lower in the follicular phase of conceptional than of non-conceptional cycles after ovarian stimulation with a gonadotrophin-releasing hormone agonist protocol. Hum. Reprod. 7: 1365–1370.PubMedGoogle Scholar
  9. Andersen, C., Morineau, G., Fukuda, M., et al. (1999). Assessment of the follicular cortisol:cortisone ratio. Hum. Reprod. 14: 1563–1568.PubMedGoogle Scholar
  10. Arriza, J., Weinbergerm C., Cerelli, G., et al. (1987). Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237: 268–275.PubMedGoogle Scholar
  11. Barroso, G., Oehninger, S., Monzo, A., et al. (2001). High FSH:LH ratio and low LH levels in basal cycle day 3: impact on follicular development and IVF outcome. J. Assisted Reprod. Genet. 18: 499–505.Google Scholar
  12. Battaglia, C., Genazzani, A., Regnani, G., et al. (2000). Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders. Fertil. Steril 74: 809–812.PubMedGoogle Scholar
  13. Benifla, J., Bringuier, A., Sifer, C., et al. (2001). Vascular endothelial growth factor, platelet endothelial cell adhesion molecule-1 and vascular cell adhesion molecule-1 in the follicular fluid of patients undergoing IVF. Hum. Reprod. 16: 1376–1381.PubMedGoogle Scholar
  14. Bider, D., Shine, S., Tur-Kaspa, I, et al. (1998). Cortisol concentrations in follicular fluid of “low responder” patients. Hum. Reprod. 13: 27–29.PubMedGoogle Scholar
  15. Branisteanu, I., Pijnenborg, R., Spiessens, C. et al. (1997). Detection of immunoreactive interleukin-11 in human follicular fluid: correlations with ovarian steroid, insulin-like growth factor I levels, and follicular maturity. Fertil. Steril. 67: 1054–1058.PubMedGoogle Scholar
  16. Bush, I., Hunter, S. and Meigs, R. (1968) Metabolism of 11-oxygenated steroids. Biochem. J. 107: 239–258PubMedGoogle Scholar
  17. Çanario, A., Scott, A. and Flint A. (1989). Radioimmunoassay investigations of 20ß-hydroxylated steroids in maturing/ovulating female rainbow trout (Salmo gairdneri). Gen. Comp. Endocr. 74: 77–84.PubMedGoogle Scholar
  18. Chen, W., Yang, J. and Li, P. (2000). Effect of dexamethasone on the expression of p34(cdc2) and cyclin B l in pig oocytes in vitro. Mol. Reprod. Devel. 56: 74–79.PubMedGoogle Scholar
  19. Chenette, P., Sauer, M. and Paulson. R. (1990). Very high serum estradiol levels are not detrimental to clinical outcome of in vitro fertilization. Fertil. Steril 54: 858–863.PubMedGoogle Scholar
  20. Chicz, R., Nakamura, R., Goebelsmann, U,et al. (1985). Follicle regulatory protein noncompetitively inhibits microsomal 3ß-hydroxysteroid dehydrogenase activity. J. Steroid Biochem. 23: 663–668PubMedGoogle Scholar
  21. Costello, M., Hughes, G, Garrett, D., et al (2001). Prognostic value of baseline serum oestradiol in controlled ovarian hyperstimulation of women with unexplained infertility. Austr. And New Zealand J. Obstet. Gyn. 41: 69–74.Google Scholar
  22. Creus, M., Penarrubia, J., Fabregues, F,. et al. (2000). Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum. Reprod. 15: 2341–2346.PubMedGoogle Scholar
  23. de Kretser. D. (1990). Inhibin. Mol. Cell. Endocr. 69: C17–C20.Google Scholar
  24. Dirnfeld, M., Lejeune, B., Camus, M., et al. (1985). Growth rate of follicular estrogen secretion in relation to the outcome of in vitro fertilization and embryo replacement. Fertil. Steril 43: 379–384.PubMedGoogle Scholar
  25. Dirnfeld, M,. Goldman, S., Gonen, Y., et al. (1993). A modest increase in serum progesterone levels on the day of human chorionic gonadotropin (hCG) administration may influence pregnancy rate and pregnancy loss in in vitro fertilization-embryo transfer (IVF-ET) patients. J. Assist. Reprod. Genet 10: 126–129.PubMedGoogle Scholar
  26. Dor, J.D., Ben-Shlomo, I., Levran, D., et al. (1992). The prognostic importance of the number of oocytes retrieved and estradiol levels in poor and normal responders in in vitro fertilization (IVF) treatment. J. Assist. Reprod. Genet. 9: 228–232.PubMedGoogle Scholar
  27. Downs, S. (2001) A gap-junction-mediated signal, rather than an external paracrine factor, predominates during meiotic induction in isolated mouse oocytes. Zygote 9: 71–82.PubMedGoogle Scholar
  28. Downs, S., Humpherson, P. and Leese H. (2002). Pyruvate utilization by mouse oocytes is influencled by meiotic status and the cumulus oophorus. Mol. Reprod. Devel. 61: 113–123.Google Scholar
  29. Driancourt, M., Guet, P., Reynaud, K., et al. (1999). Presence of an aromatase inhibitor, possibly heat shock protein 90, in dominant follicles of cattle. J. Reprod. Fertil. 115: 45–58.PubMedGoogle Scholar
  30. Driancourt, M., Guet P. and Magallon, T. (2000). Ovine follicular fluid inhibits aromatase activity. Dom. Anim. Endocr. 18: 349–362.Google Scholar
  31. Duax, W. and Ghosh, D. (1997). Structure and function of steroid dehydrogenases involved in hypertension, fertility, and cancer. Steroids 62 pp: 95–100.PubMedGoogle Scholar
  32. Edelstein, M., Seltman, J, Cox. B., et al. (1990) Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome. Fertli. Steril 54: 853–857.Google Scholar
  33. Eldar-Geva, T., Margalioth E., Brooks B., et al. (1997.) Elevated serum progesterone levels during pituitary suppression may signify adrenal hyperandrogenism. Fertil. Steril 67: 959–961.PubMedGoogle Scholar
  34. Fanchin, R., de Ziegler, D., Taieb, J., et al. (1993). Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil. Steril 59: 1090–1094.PubMedGoogle Scholar
  35. Fanchin, R., Righini, C., Olivennes, F., et al. (1996). Premature progesterone elevation does not alter oocyte quality in in vitro fertilization. Fertil. Steril. 65: 1178–1183.PubMedGoogle Scholar
  36. Fanchin, R., Righini, C., Olivennes, F.,. (1997). Consequences of premature progesterone elevation on the outcome of in vitro fertilization: insights into a controversy. Fertil. Steril 68: 799–805.PubMedGoogle Scholar
  37. Fateh, M., Ben-Rafael, Z., Benadiva, C., et al. (1989). Cortisol levels in human follicular fluid. Fertil. Steril. 51: 538–541.PubMedGoogle Scholar
  38. Forman, R., Robinson, J., Egan, D., et al. (1991). Follicular monitoring and outcome of in vitro fertilization in gonadotropin-releasing hormone-agonist-treated cycles. Fertil. Steril 55: 567–573.PubMedGoogle Scholar
  39. Fowkes, R., Chandras, C., Chin, E., et al. (2001). Relationship between the production of Prostaglandins and progesterone by luteinizing human granulosa cells. J. Endocr. 171: 455–462.PubMedGoogle Scholar
  40. Franchimont, P., Hazee-Hagelstein, M., Hazout, A., et al. (1989). Correlation between follicular fluid content and the results of in vitro fertilization and embryo transfer. I. Sex steroids. Fertil. Steril. 52: 1006–1011.Google Scholar
  41. Franchimont,.P, Hazee-Hagelstein, M., Charlet-Renard, C., et al. (1999). Correlation between follicular fluid content and the results of in vitro fertilization and embryo transfer. II. Inhibin and aromatase inhibitor activity. J. Clin. Endocr. Metabol. 71: 748–754.Google Scholar
  42. Fried, G., and Wramsby, H. (1998). Increase in transforming growth factor ßl in ovarian follicular fluid following ovarian stimulation and in-vitro fertilization correlates to pregnancy. Hum. Reprod. 13: 656–659.PubMedGoogle Scholar
  43. Friedman, C., Seifer, D., Kennard, E., et al. (1998). Elevated level of follicular fluid vascular endothelial growth factor is a marker of diminished pregnancy potential. Fertil. Steril. 70:836–839.PubMedGoogle Scholar
  44. Funder, J. (1991) Steroids, receptors, and response elements: the limits of signal specificity. Rec. Prog. Horm. Res. 47: 191–207.PubMedGoogle Scholar
  45. Funder, J., Pearce, P., Smith, R. and Smith, A. (1988). Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242: 583–585.PubMedGoogle Scholar
  46. Gao, H., Shan, L., Monder, C. and Hardy, M. (1996). Supression of endogenous corticosterone levels in vivo increases the steroidogenic capacity of purified rat Leydig cells in vitro. Endocr. 137: 1714–1718.Google Scholar
  47. Ge R., Gao, H., Nacharaju, V. et al. (1997). Identification of a kinetically distinct activity of 1 ß-hydroxysteroid dehydrogenase in rat Leydig cells. Endocr. 138: 2435–2442.Google Scholar
  48. Ge, R. and Hardy, M. (2000). Initial predominance of the oxidative activity of type 1 11ß-hydroxysteroid dehydrogenase in primary rat Leydig cells and transfected cell lines. J. Androl. 21:303–310.PubMedGoogle Scholar
  49. Geva, E, Lessing J., Lerner-Geva L, et al. (1997). Interleukin-10 in preovulatory follicular fluid of patients undergoing in-vitro fertilization and embryo transfer. Am. J. Reprod. Imm. 37: 187–190.Google Scholar
  50. Girmus, R. and Ledwitz-Rigby, F. (1987). Follicular fluid stimulation of 3ß-hydroxysteroid dehydrogenase activity in vitro. Biol. Reprod. 37: 1215–1223.PubMedGoogle Scholar
  51. Givens, C., Schriock E. Dandekar, P. and Martin, M. (1994). Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles. Fertil. Steril. 62: 1011–1017.PubMedGoogle Scholar
  52. Gonen, Y. and Casper, R. (1989) Does transient hyperprolactinemia during hyperstimulation interfere with conception or pregnancy outcome? Fertil. Steril. 51: 1007–1010.PubMedGoogle Scholar
  53. Gonen, Y., Dirnfeld M., Goldman, S., Koifman, M. and Abramovici, H. (1993), Preovulatory progesterone growth rate in patients treated with gonadotrophin-releasing hormone agonist and outcome of in-vitro fertilization. Hum. Reprod. 8: 1376–1379.PubMedGoogle Scholar
  54. Hall, J., Welt, C. and Cramer, D. (1999). Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum. Reprod. 14: 409–415.PubMedGoogle Scholar
  55. Hammadeh, M., Ertan A., Zeppezauer, M,, et al. (2002). Immunoglobulins and cytokines level in follicular fluid in relation to etiology of infertility and their relevance to IVF outcome. Am. J. Repro. Imm. 47: 82–90.Google Scholar
  56. Harada, T., Yoshida, S., Katagiri, C., et al. (1995). Reduced implantation rate associated with a subtle rise in serum progesterone concentration during the follicular phase of cycles stimulated with a combination of a gonadotrophin-releasing hormone agonist and gonadotrophin. Hum. Reprod. 10: 1060–1064.PubMedGoogle Scholar
  57. Harada, T., Katagiri, C., Takao N., et al. (1996). Altering the timing of human chorionic gonadotropin injection according to serum progesterone (P) concentrations improves embryo quality in cycles with subtle Prise. Fertil. Steril. 65: 594–597.PubMedGoogle Scholar
  58. Harlow, C., Jenkins J. and Winston, R. (1997). Increased follicular fluid total and free cortisol during the luteinizing hormone surge. Fertil. Steril. 68: 48–53.PubMedGoogle Scholar
  59. Hassiakos, D., Toner J., Muasher, S, and Jones, H. Jr. (1990). Implantation and pregnancy rates in relation to oestradiol and progesterone profiles in cycles with and without the use of gonadotrophin-releasing hormone agonist suppression. Hum. Reprod. 5: 1004–1008.PubMedGoogle Scholar
  60. Hofmann, G., Denis, A., Scott. R. and Muasher, S. (1989). The incidence of transient hyperprolactinemia in gonadotropin-stimulated cycles for in vitro fertilization and its effect on pregnancy outcome. Fertil. Steril. 52: 622–626.PubMedGoogle Scholar
  61. Hofmann, G., Khoury J., Johnson, C., et al. (1996). Premature luteinization during controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer has no impact on pregnancy outcome. Fertil. Steril. 66: 980–986.PubMedGoogle Scholar
  62. Holmes, M., Kotelevstev, Y., Mullins, J. and Seckl, J. (2001). Phenotypic analysis of mice bearing targeted deletions of 1 ß-hydroxysteroid dehydrogenases 1 and 2 genes. Mol. Cell. Endocr. 171: 15–20.Google Scholar
  63. Houghton, F., Thompson, J., Kennedy, C. and Leese, H. (1996). Oxygen consumption and energy metabolism of the early mouse embryo. Mol. Reprod. Devel. 44: 476–485.PubMedGoogle Scholar
  64. Houghton, F., Hawkhead, J., Humpherson, P. et al. (2002). Non-invasive amino acid turnover predicts human embryo developmental capacity. Hum. Reprod. 17: 999–1005.PubMedGoogle Scholar
  65. Howies, C, Macnamee, M. and Edwards, R. (1987). Follicular development and early luteal function of conception and non-conceptional cycles after human in-vitro fertilization: endocrine correlates. Hum. Reprod. 2: 17–21.Google Scholar
  66. Huang, J., Jackson, K., Hornstein, M. and Ginsburg, E. (1996). The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer. J. Assist. Reprod. Genet. 13:617–624.PubMedGoogle Scholar
  67. Hughes, E., Robertson, D., Handelsman, D., et al. (1990). Inhibin and estradiol responses to ovarian hyperstimulation: effects of age and predictive value for vitro fertilization outcome. J. Clin. Endocr. Metabol. 70: 358–364.Google Scholar
  68. Hummel, W., Clark, M. and Talbert, L. (1990). Transient hyperprolactinemia during cycle Stimulation and its influence on oocyte retrieval and fertilization rates. Fertil. Steril 53: 677–681.PubMedGoogle Scholar
  69. Jimena, P, Castilla, J., Peran,. F., et al. (1992). Adrenal hormones in follicular fluid. Acta Endocrinologica 127: 403–406.PubMedGoogle Scholar
  70. Kadam, A., Moodbidri, S. and Nandedkar, T. (1984). Inhibition of 3ß-hydroxysteroid dehydrogenase (3ß-HSD) activity in the granulosa cells of mouse ovarian follicles by follicular fluid peptide. Steroids 44: 497–509.PubMedGoogle Scholar
  71. Kagawa, T., Yamano, S., Nishida, S., (1992). Relationship among serum levels of luteinizing hormone, estradiol, and progesterone during follicle stimulation and results of in vitro fertilization and embryo transfer (IVF-ET). J. Assist. Reprod. Genet. 9: 106–112PubMedGoogle Scholar
  72. Karagouni, E. Chryssikopoulos, A., Mantzavinos, T. et al. (1998). Interleukin-lß and interleukin-lα may affect the implantation rate of patients undergoing in vitro fertilizationembryo transfer. Fertil. Steril 70: 553–559PubMedGoogle Scholar
  73. Kavic, S., Cohen, M., Sauer, M. and Lindheim, S. (2001). Controlled ovarian hyperstimulation. Relationship of early serum E2 levels to the ultimate response of oocyte donors. J. Reprod. Med. 46: 637–640.PubMedGoogle Scholar
  74. Keay, S., Harlow, C., Wood, P., et al. (2002). Higher cortisol Cortisone ratios in the preovulatory follicle of unstimulated IVF cycles indicate oocytes with increased pregnancy potential. Hum. Reprod. 17: 2003–2008.PubMedGoogle Scholar
  75. Khalaf, Y, Taylor, A. and Braude, P. (2000). Low serum estradiol concentrations after five days of controlled ovarian hyperstimulation for in vitro fertilization are associated with poor outcome. Fertil. Steril. 74: 63–66.PubMedGoogle Scholar
  76. Kirne, D., Scott, A. and Canario, A. (1992). In vitro biosynthesis of steroids, including 11-deoxycortisol and 5α-pregnane-3ß,7α,17,20ß-tetrol, by ovaries of the goldfish Carassius auratus during the stage of oocyte final maturation. Gen. Comp. Endocr. 87: 375–384.Google Scholar
  77. King, W., Ghosh, S., Thomas, P. and Sullivan, C. (1997). A receptor for the oocyte maturation-inducing hormone, 17α,20ß,21-trihydroxy-4-pregnen-3-one on ovarian membranes of striped bass. Biol. Reprod. 56: 266–271.PubMedGoogle Scholar
  78. Kobayashi, T., Oda, T., Yoshimura, Y. et al. (1991). Androstenedione and progesterone concentrations in preovulatory follicular fluid correlate with successful fertilization and cleavage of human oocytes in vitro. Fertil. Steril 56: 301–305.PubMedGoogle Scholar
  79. Kotelevstev, Y., Jamieson, P., Best, R., et al. (1996). Inactivation of 11ß-hydroxysteroid dehydrogenase type 1 by gene targeting in mice. Endocr. Res. 22: 791–792.Google Scholar
  80. Kumar, R. and Thompson, E. (1999). The structure of the nuclear hormone receptors. Steroids 64:310–319.PubMedGoogle Scholar
  81. Kupesic, S. and Kurjak, A. (2002). Predictors of IVF outcome by three-dimensional ultrasound. Hum. Reprod. 17: 950–955.PubMedGoogle Scholar
  82. Lee, A., Christenson, L., Stouffer, R., et al. (1997). Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization. Fertil. Steril 68: 305–311.PubMedGoogle Scholar
  83. Legro, R., Ary, B., Paulson R. et al. (1993). Premature luteinization as detected by elevated serum progesterone is associated with a higher pregnancy rate in donor oocyte in-vitro fertilization. Hum. Reprod. 8: 1506–1511.PubMedGoogle Scholar
  84. Leyendecker, G., Bernart, W., Bremen, T., et al. (1990). Influence of the duration of the oestradiol rise on the success rate in GnRH analogue/HMG-stimulated IVF cycles. Hum. Reprod. 5: 52–55.PubMedGoogle Scholar
  85. Licciardi, F., Liu, H. and Rosenwaks, Z. (1995). Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil. Steril 64: 991–994.PubMedGoogle Scholar
  86. Lo, Y., Sheff, M., Latif, S., et al. (1997). Kidney 11ß-HSD2 is inhibited by glycyrrhetinic acid-like factors in human urine. Hypertension 29: 500–505.PubMedGoogle Scholar
  87. Loumaye, E., Engrand, P., Howies, C. and O’Dea. L. (1997). Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome. Fertil. Steril 67: 889–899.PubMedGoogle Scholar
  88. Manau, D., Balasch, J., Jimenez, W., et al. (2000). Follicular fluid concentrations of adrenomedullin, vascular endothelial growth factor and nitric oxide in IVF cycles: relationship to ovarian response. Hum. Reprod. 15: 1295–1299.PubMedGoogle Scholar
  89. Mantzavinos, T., Phocas, I., Vitoratos, N., et al. (1997). Comparison between steroid hormones and cortisol in serum and follicular fluid in stimulated and unstimulated cycles of in vitro fertilization patients. Gynecol. Endocr. 11: 163–168.Google Scholar
  90. Marandici, A. and Monder, C. (1993). Inhibition by glycyrrhetinic acid or rat tissue Hß-hydroxysteroid dehydrogenase in vivo. Steroids 58: 153–156.PubMedGoogle Scholar
  91. McWilliam, R., Leake, R. and Coutts, J. (1995). Growth factors in human ovarian follicle fluid and growth factor receptors in granulosa-luteal cells. Intern. J. Biol. Markers 10: 216–220.Google Scholar
  92. Mendoza, C., Cremades, N., Ruiz-Requena, E., et al. (1999). Relationship between fertilization results after intracytoplasmic sperm injection, and intrafollicular steroid, pituitary hormone and cytokine concentrations. Hum. Reprod. 14: 628–635.PubMedGoogle Scholar
  93. Mettler, L. and Tavmergen, E. (1989). Significance of oestradiol values in IVF-ET under a combined GnRH analogue-desensitization and simultaneous gonadotrophin stimulation for the outcome of pregnancies. Hum. Reprod. 4(Suppl.): 59–64.PubMedGoogle Scholar
  94. Meyer, W., Beyler, S., Baker, S. et al. (1999). Value of estradiol response after human chorionic gonadotropin administration in predicting in vitro fertilization success. Fertil. Steril 72: 542–545.PubMedGoogle Scholar
  95. Michael, A., Pester, L., Curtis, P., et al. (1993a). Direct inhibition of ovarian steroidogenesis by cortisol and the modulatory role of 11ß-hydroxysteroid dehydrogenase. Clin. Endocr. 38: 641–644.PubMedGoogle Scholar
  96. Michael, A., Gregory, L., Walker, S., et al. (1993b). Ovarian 11ß-hydroxysteroid dehydrogenase: potential predictor of conception by in-vitro fertilization and embryo transfer. Lancet 342: 711–712.PubMedGoogle Scholar
  97. Michael, A., Gregory, L., Piercy, E., et al. (1995). Ovarian 11ß-hydroxysteroid dehydrogenase activity is inversely related to the outcome of in vitro fertilization-embryo transfer treatment cycles. Fertil. Steril 64: 590–598.PubMedGoogle Scholar
  98. Michael, A., Gregory, L., Thaventhiran, L., et al. (1996). Follicular variation in ovarian 11ß-hydroxysteroid dehydrogenase (1 lßHSD) activities: evidence for the paracrine inhibition of lßHSD in human granulosa-lutein cells. J. Endocr. 148: 419–425.PubMedGoogle Scholar
  99. Michael, A., Evagelatou, M., Norgate, D., et al. (1997). Isoforms of 11ß-hydroxysteroid dehydrogenase in human granulosa-lutein cells. Mol. Cell. Endocr. 132: 43–52.Google Scholar
  100. Michael, A., Collins, T., Norgate, D., et al. (1999). Relationship between ovarian cortisolxortisone ratios and the clinical outcome of in vitro fertilization and embryo transfer (IVF-ET). Clin. Endocr. 51: 535–540.PubMedGoogle Scholar
  101. Mikkelsen, A. Andersson, A., Skakkebaek, N. and Lindenberg, S. (2001). Basal concentrations of oestradiol may predict the outcome of in-vitro maturation in regularly menstruating women. Hum. Reprod. 16: 862–867.PubMedGoogle Scholar
  102. Mio, Y., Sekijima, A., Iwabe, T.„et al. (1992). Subtle rise in serum progesterone during the follicular phase as a predictor of the outcome of in vitro fertilization. Fertil. Steril 58: 159–166.PubMedGoogle Scholar
  103. Moffitt, D., Queenan, J. Jr., Shaw, R. and Muasher, S. (1997). Progesterone levels on the day of human chorionic gonadotropin do not predict pregnancy outcome from the transfer of fresh or cryopreserved embryos from the same cohort. Fertil. Steril 67: 296–301.PubMedGoogle Scholar
  104. Monder, C. (1991). Corticosteroids, receptors, and the organ-specific functions of 11 ß-hydroxysteroid dehydrogenase. FASEB J. 5: 3047–3054.PubMedGoogle Scholar
  105. Monder, C., Miroff, Y., Marandici, A. and Hardy, M. (1994). 1 l ß-Hydroxysteroid dehydrogenase alleviates glucocorticoid-mediated inhibition of steroidogenesis in rat Leydig cells. Endocr. 134: 1199–1204.Google Scholar
  106. Morris, D., Semafuko, W., Latif, S., et al. (1992). Detection of glycyrrhetinic acid-like factors (GALFs) in human urine. Hypertension 20: 356–360.PubMedGoogle Scholar
  107. Mugnier, C., Gaignon, J. and Fostier, A. (1997). In vitro synthesis of 17,20ß,21-trihydroxy-4-pregnen-3-one by ovaries of turbot (Scophthalmus maximus L during oocyte maturation. Gen. Comp. Endocr. 107: 63–73.PubMedGoogle Scholar
  108. Munabi, A., King, D., Bender, S., et al. (1990) Small increases in circulating luteinizing hormone (LH) concentrations shortly before human chorionic gonadotropin (hCG) are associated with reduced in vitro fertilization (IVF) pregnancy rate. J. IVF Embr. Trans. 7: 310–313Google Scholar
  109. Nacharaju, V., Muneyyirci-Delale, O. and Khan, N (1997). Presence of 11ß-hydroxysteroid dehydrogenase in human semen: evidence of correlation with semen characteristics. Steroids 62: 311–314.PubMedGoogle Scholar
  110. Noci, I., Maggi, M., Fuzzi, B., et al. (2000). Effects of low day 3 luteinizing hormone levels on in vitro fertilization treatment outcome. Gyn. Endocr. 14: 321–326.Google Scholar
  111. Norgate, D., Thurston, L., Kloosterboer, H., et al. (2002). Resolution of endogenous ovarian modulators of 11ß-hydroxysteroid dehydrogenase (1 l ßHSD) activities from human follicular fluid (hFF). 84th Ann. Meeting of the Endocrine Society: Abstract P2-445.Google Scholar
  112. Oda, T., Yoshimura, Y., Takehara. Y., et al. (1991). Effects of prolactin on fertilization and cleavage of human oocytes. Horm. Res. 35(Suppl. 1): 33–38.PubMedGoogle Scholar
  113. O’Shaughnessy, A., Muneyyirci-Delale, O., Nacharaju, V., (1997). l lß-Hydroxysteroid dehydrogenase enzyme activity in granulosa cells derived from ovarian follicles of in vitro fertilization patients. Early Pregnancy 3: 183–189.PubMedGoogle Scholar
  114. Owen, E., Holownia, P., Conway, G., et al. (1992). 11ß-Hydroxyandrostenedione in plasma, follicular fluid, and granulosa cells of women with normal and polycystic ovaries. Fertil. Steril 58: 713–718.PubMedGoogle Scholar
  115. Padilla, S., Bayati, J. and Garcia, J. (1990). Prognostic value of the early serum estradiol response to leuprolide acetate in in vitro fertilization. Fertil. Steril 53: 288–294.PubMedGoogle Scholar
  116. Patino, R. and Thomas, P. (1990). Induction of maturation in Atlantic croaker oocytes by 17α,20ß,21-trihydroxy-4-pregnen-3-one in vitro: consideration of some biological and experimental variables. J. Exp. Zool. 255: 97–109.PubMedGoogle Scholar
  117. Pattinson, H., Taylor, P., Fleetham, J. and Servis, S. (1990). Transient hyperprolactinemia has no effect on endocrine response and outcome in in vitro fertilization (IVF). J. IVF Embr. Trans. 7: 89–93.Google Scholar
  118. Penarrubia, J., Balasch, J., Fabregues, F., et al. (2000). Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment. Hum. Reprod. 15: 1499–1504.PubMedGoogle Scholar
  119. Penzias, A., Shamma, F., Gutmann, J., et al. (1992). Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonistsuppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles. J. Assist. Reprod. Genet. 9: 244–247.PubMedGoogle Scholar
  120. Petrino, T., Lin, Y., Netherton, J., et al. (1993). Steroidogenesis in Fundulus heteroclitus V: purification, characterization, and metabolism of 17α,20ß-dihydroxy-4-pregnen-3-one by intact follicles and its role in oocyte maturation. Gen. Comp. Endocrinol. 92: 1–15.PubMedGoogle Scholar
  121. Phelps, J., Levine, A., Hickman, Tet al. (1998). Day 4 estradiol levels predict pregnancy success in women undergoing controlled ovarian hyperstimulation for IVF. Fertil. Steril 69: 1015–1019PubMedGoogle Scholar
  122. Phillips, D., Lakshmi, V. and Monder, C. (1989), Corticosteroid 11 ß-dehydrogenase in rat testis. Endocr. 125:209–216.Google Scholar
  123. Phopong, P., Ranieri, D., Khadum, I., et al (2000). Basal 17 ß-estradiol did not correlate with ovarian response and in vitro fertilization treatment outcome. Fertil. Steril. 74:1133–1136.Google Scholar
  124. Pinter, J. and Thomas, P. (1999). Induction of ovulation of mature oocytes by the maturationinducing steroid 17,20ß,21-trihydroxy-4-pregnen-3-one in the spotted seatrout. Gen. Comp. Endocr. 115:200–209.PubMedGoogle Scholar
  125. Prien, S., Canez, M. and Messer, R. (1994). Increases in progesterone after human chorionic gonadotropin administration may predict cycle outcome in patients undergoing in vitro fertilization-embryo transfer. Fertil.Steril 62: 1066–1068.PubMedGoogle Scholar
  126. Prien, S., Canez, M. and Messer, R. (2000). The dosage of human chorionic gonadotropins influences the relationship between progesterone and cycle outcome during in vitro fertilization-embryo transfer. Intern. J. Fertil. Womens Med. 45: 258–263.Google Scholar
  127. Rajan, V., Chapman, K., Lyons, V., et al. (1995) Cloning, sequencing and tissue-distribution of mouse 11 ß-hydroxysteroid dehydrogenase-1 cDNA. J. Steroid Biochem. Mol. Biol. 52: 141–147.PubMedGoogle Scholar
  128. Reljic, M., Vlaisavljevic, V., Gavric, V., et al. (2001). Value of the serum estradiol level on the day of human chorionic gonadotropin injection and on the day after in predicting the outcome in natural in vitro fertilization/intracytoplasmic sperm injection cycles. Fertil. Steril 75: 539–543.PubMedGoogle Scholar
  129. Sankar, B., Maran, R., Sudha, S., et al (2000). Chronic corticosterone treatment impairs Leydig cell 11 ß-hydroxysteroid dehydrogenase activity and LH-stimulated testosterone production. Horm. Metab. Res. 32: 142–146PubMedGoogle Scholar
  130. Schalkoff, M., Oskowitz, S. and Powers, R. (1993). A multifactorial analysis of the pregnancy outcome in a successful embryo cryopreservation program. Fertil. Steril. 59: 1070–1074.PubMedGoogle Scholar
  131. Schoolcraft, W., Sinton, E., Schlenker, T., et al. (1991). Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil. Steril. 55: 563–566.PubMedGoogle Scholar
  132. Schoonen, W., Penders, M., Van Dam, G. and Lambert, J. (1988). 5ß-Pregnane-3α, 6α,17α,20ß-tetrol and 5ß-pregnane-3α,6α,17α-triol-20-one: steroids of ovarian origin in the African catfish, Clarias gariepinus, during oocyte maturation. Gen. Comp. Endocr. 69: 181–187.PubMedGoogle Scholar
  133. Scott, A. and Canario, A. (1990). Plasma levels of ovarian steroids, including 17α,21-dihydroxy-4-pregnene-3,20-dione and 3α,17α,21-trihydroxy-5ß-pregnan-20-one, in female plaice (Pleuronectes platessa) induced to mature with human chorionic gonadotrophin. Gen. Comp. Endocr. 78: 286–298.PubMedGoogle Scholar
  134. Scott, R., Toner, J., Muasher, S., et al. (1989) Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil. Steril 51: 651–654.PubMedGoogle Scholar
  135. Seibel, M., Kearnan, M. and Kiessling, A. (1995). Parameters that predict success for natural cycle in vitro fertilization-embryo transfer. Fertil. Steril. 63: 1251–1254.PubMedGoogle Scholar
  136. Seifer, D., Gardiner, A., Lambert-Messerlian, G. and Schneyer, A. (1996). Differential secretion of dimeric inhibin in cultured luteinized granulosa cells as a function of ovarian reserve. J. Clin. Endocr. Metabol. 81: 736–739.Google Scholar
  137. Seifer, D., Lambert-Messerlian, G., Hogan, J., et al. (1997). Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Ferti. Steril 67: 110–114.Google Scholar
  138. Sharara, F. and McClamrock, H. (1999a). High estradiol levels and high oocyte yield are not detrimental to in vitro fertilization outcome. Fertil. Steril 72: 401–405.PubMedGoogle Scholar
  139. Sharara, F. and McClamrock, H. (1999b). Ratio of oestradiol concentration on the day of human chorionic gonadotrophin administration to mid-luteal oestradiol concentration is predictive of in-vitro fertilization outcome. Hum. Reprod. 14: 2777–2782.PubMedGoogle Scholar
  140. Sharif, K., Elgendy, M., Lashen, H. and Afnan, M. (1998). Age and basal follicle stimulating hormone as predictors of in vitro fertilization outcome. Brit. J. Obstet. Gynaecol. 105: 107–112.Google Scholar
  141. Shulman, A., Ghetler, Y., Beyth, Y. and Ben-Nun, I. (1996). The significance of an early (premature) rise of plasma progesterone in in vitro fertilization cycles induced by a “long protocol” of gonadotropin releasing hormone analogue and human menopausal gonadotropins. J. Assist. Reprod. Genet. 13: 207–211.PubMedGoogle Scholar
  142. Silverberg, K., Burns, W., Olive, D., et al. (1991). Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins. J. Clin. Endocr. Metabol. 73: 797–803.Google Scholar
  143. Silverberg, K., Martin, M., Olive, D., et al. (1994). Elevated serum progesterone levels on the day of human chorionic gonadotropin administration in in vitro fertilization cycles do not adversely affect embryo quality. Fertil. Steril 61: 508–513.PubMedGoogle Scholar
  144. Simon, C., Cano, F., Valbuena, D., et al. (1995). Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients. Hum. Reprod. 10: 2432–2437.PubMedGoogle Scholar
  145. Sims, J., Seltman, H. and Muasher, S. (1994). Early follicular rise of serum progesterone concentration in response to a flare-up effect of gonadotrophin-releasing hormone agonist impairs follicular recruitment for in-vitro fertilization. Hum. Reprod. 9: 235–240.PubMedGoogle Scholar
  146. Smith, M., Keay, S., Hall, L., et al. (1997). The detection and confirmation of 11ß-hydroxysteroid dehydrogenase type 1 transcripts in human luteinized granulosa cells using RT-PCR and plasmid pUC18. Mol. Hum. Reprod. 3: 651–654.PubMedGoogle Scholar
  147. Smith, M., Mathur, R., Keay, S., Hall, L., et al. (2000) Periovulatory human oocytes, cumulus cells, and ovarian leukocytes express type 1 but not type 2 11ß-hydroxysteroid dehydrogenase RNA. Fertil. Steril. 73: 825–830.PubMedGoogle Scholar
  148. Smotrich, D., Widra, E., Gindoff, P., et al. (1995). Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertil. Steril. 64: 1136–1140.PubMedGoogle Scholar
  149. Souness, G., Latif, S., Laurenzo, J. and Morris, D. (1995). 11α-and 11ß-hydroxyprogesterone, potent inhibitors of lβ1-hydroxysteroid dehydrogenase (isoforms 1 and 2), confer marked mineralocorticoid activity on corticosterone in the ADX rat. Endocr. 136: 1809–1812.Google Scholar
  150. Souness, G. and Morris, D. (1996). 11α-and 11ß-hydroxyprogesterone, potent inhibitors of 11ß-hydroxysteroid dehydrogenase, possess hypertensinogenic activity in the rat. Hypertension 27: 421–425.PubMedGoogle Scholar
  151. Stewart, P., Wallace, A., Atherden, S., et al.(1990). Mineralcorticoid actibity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11ß-hydroxysteroid dehydrogenase in man. Clin. Sci. 78: 49–54.PubMedGoogle Scholar
  152. Tannin, G., Agarwal, A., Monder, C., et al.(1991). The human gene for 11ß-hydroxysteroid dehydrogenase. Structure, tissue distribution and chromosomal localization. J. Biol. Chem. 266: 16653–16658.PubMedGoogle Scholar
  153. Tetsuka, M., Thomas, F., Thomas, M., et al. (1997) Differential expression of messenger ribonucleic acids encoding 11ß-hydroxysteroid dehydrogenase types 1 and 2 in human granulosa cells. J. Clin. Endocr. Metabol. 82: 2006–2009.Google Scholar
  154. Tetsuka, M., Haines, L., Milne, M et al. (1999). Regulation of 11ß-hydroxysteroid dehydrogenase type 1 gene expression by LH and interleukin-lß in cultured rat granulosa cells. J. Endocr. 163:17–423.Google Scholar
  155. Thomas, F., Thomas, M., Tetsuka, M et al. (1998) Corticosteroid metabolism in human granulosa-lutein cells. Clin. Endocr. 48: 509–513.PubMedGoogle Scholar
  156. Thurston, L., Norgate, D., Jonas, K, et al (2002a) Endogenous ovarian modulators of 11ß-hydroxysteroid dehydrogenase (11ßHSD) activity correlate cortisol/cortisone ratios in human follicular fluid (hFF). Reproduction (Suppl.) Abstract Series No.28: Abstract 25Google Scholar
  157. Thurston, L., Norgate, D., Jonas, K., et al. (2002b). Endogenous modulators of 11ß-hydroxysteroid dehydrogenase (11ßHSD) activity and cortisol/cortisone ratios in human follicular fluid (hFF) correlate with the outcome of in vitro fertilizsation-embryo transfer (IVF-ET). Reproduction (Suppl.) Abstract Series No.28: Abstract 26.Google Scholar
  158. Tonetta, S., Stone, B., Marrs, R. and diZerega, G. (1990). Concentrations of follicle regulatory protein, steroids and gonadotrophins in antral fluids from women stimulated with metrodin and hCG. J. Reprod. Fertil. 88: 389–397.PubMedGoogle Scholar
  159. Trant, J. and Thomas, P. (1989). Isolation of a novel maturation-inducing steroid produced in vitro by ovaries of Atlantic croaker. Gen. Comp. Endocr. 75: 397–404.PubMedGoogle Scholar
  160. Ubaldi, F., Smitz, J., Wisanto, A., et al. (1995). Oocyte and embryo quality as well as pregnancy rate in intracytoplasmic sperm injection are not affected by high follicular phase serum progesterone. Hum. Reprod. 10: 3091–3096.PubMedGoogle Scholar
  161. Urbancsek J., Rabe, T., Grunwald, K., et al. (1992). Serum inhibin levels in gonadotrophin stimulated in-vitro fertilization/gamete intra-fallopian transfer cycles. Hum. Reprod. 7: 1195–1200PubMedGoogle Scholar
  162. Urman, B., Alatas, C., Aksoy, S., et al. (1999). Elevated serum progesterone level on the day of human chorionic gonadotropin administration does not adversely affect implantation rates after intracytoplasmic sperm injection and embryo transfer. Fertil. Steril. 72: 975–979.PubMedGoogle Scholar
  163. Watt, A., Legedza, A., Ginsburg, E., et al. (2000). The prognostic value of age and folliclestimulating hormone levels in women over forty years of age undergoing in vitro fertilization. J. Assist. Reprod. Genet. 17: 264–268.PubMedGoogle Scholar
  164. Webb R., Bains, H., Cruttwell. C. and Carroll, J. (2002). Gap-junctional communication in mouse cumulus-oocyte complexes: implications for the mechanism of meiotic maturation. Reproduction 123: 41–52.PubMedGoogle Scholar
  165. White, P., Mune, T. and Agarwal, A. (1997). 1 l ß-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralcorticoid excess. Endocr. Rev. 18: 135–156.PubMedGoogle Scholar
  166. Whitfield, G., Jurutka, P., Haussler, C. and Haussler, M. (1999). Steroid hormone receptors: evolution, ligands, and molecular basis of biologic function. J. Cell. Biochem. 110 (Suppl). 32–33.Google Scholar
  167. Yang, J-G., Chen, W-Y. and Li, P. (1999). Effects of glucocorticoids on maturation of pig oocytes and their subsequent fertilizing capacity in vitro. Biol. Reprod. 60: 929–936.PubMedGoogle Scholar
  168. Yong, P., Thing, K., Andrew, R., et al. (2000). Development-related increase in cortisol biosynthesis by human granulosa cells. J. Clin. Endocr. Metabol. 85:4728-4733Google Scholar
  169. Younis, J., Matilsky, M., Radin, O. and Ben-Ami, M. (2001). Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist. Fertil. Steril 76: 294–299.PubMedGoogle Scholar
  170. Zhou, M-Y., Gomez-Sanchez, E., Cox, D., et al.(1995).Cloning, expression and tissue distribution of the rat nicotinamide adenine dinucleotide-dependent isoform of 11ß-hydroxysteroid dehydrogenase. Endocrinol. 136: 3729–3734Google Scholar

Copyright information

© Springer Science+Business Media New York 2004

Authors and Affiliations

  • Anthony E. Michael
    • 1
  1. 1.Department of Biochemistry & Molecular BiologyRoyal Free & University College Medical School, University College LondonLondonUK

Personalised recommendations